Objective Tovalidate the ANZ model,a prognosticmodel of metastatic breast cancer among the patients of our breast cancer tumor center.Methods The data of 104 patients starting first-line treatmentfor metastatic breast cancer from Jan. 2002 to Dec. 2012 were collectedas a validation dataset for ANZ model. Results We validate the ANZ model in 104 metastatic breast cancer patientsof our breast tumor center,C-index is 0.61(,),the calibration plot suggested that the accuracy of the predicted OS using the nomogram is unsatisfied in the validation cohort. Conclusion ANZ model showed an inferior prognosticpower in the metastatic breast cancer patientsof our tumor center. A more accurate prognostic model trained by Chinese metastatic breast cancer patients is needed.
Objective To validate the ANZ model,a prognostic model of metastatic breast cancer among the patients of our breast cancer tumor center. Methods The data of 104 patients starting first-line treatment for metastatic breast cancer from Jan. 2002 to Dec. 2012 were collected as a validation dataset for ANZ model. Results We validate the ANZ model in 104 metastatic breast cancer patients of our breast tumor center,the C-index is 0.61(0.53,0.70),and the calibration plot suggested that the accuracy of the predicted OS using the nomogram is unsatisfied in the validation cohort. Conclusion ANZ model showed an inferior prognostic power in the metastatic breast cancer patients of our tumor center. A more accurate prognostic model trained by Chinese metastatic breast cancer patients is needed.